What's new

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 69, Status: Authorised

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 69, Status: Authorised

Feb 24, 2025 - 17:15
 0
Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 69, Status: Authorised
Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 69, Status: Authorised
Read More

Tags:

Previous Article

Entrada’s 2-year ordeal ends as FDA lifts hold on DMD drug

Next Article

U of Arizona hires former Cedars-Sinai cancer leader

Related Posts

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Maximum residue limits (MRL)

Maximum residue limits (MRL)

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0